Loeillot Olivier
Insider CIK 1995525 · RGEN President and CCO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-10-05 | 2026-10-06 | 4,202 | — | $0 | 8,405 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-10-05 | 2026-10-06 | 4,202 | $190.00 | $798.4K | 45,788 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-10-05 | 2026-10-06 | 4,202 | $154.96 | $651.1K | 49,990 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-10-05 | 2026-10-06 | 1,333 | $178.75 | $238.3K | 45,788 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-10-02 | 2026-10-05 | 1,248 | $181.70 | $226.8K | 47,121 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-09-24 | 2026-09-25 | 4,542 | — | $0 | 9,085 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-09-24 | 2026-09-25 | 8,404 | — | $0 | 12,607 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-24 | 2026-09-25 | 4,542 | $190.00 | $863.0K | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-09-24 | 2026-09-25 | 4,542 | $155.38 | $705.7K | 52,911 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-09-24 | 2026-09-25 | 8,404 | $154.96 | $1.30M | 56,773 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-24 | 2026-09-25 | 8,404 | $190.00 | $1.60M | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-09-24 | 2026-09-25 | 4,542 | — | $0 | 9,085 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-09-24 | 2026-09-25 | 8,404 | — | $0 | 12,607 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-24 | 2026-09-25 | 4,542 | $190.00 | $863.0K | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-09-24 | 2026-09-25 | 4,542 | $155.38 | $705.7K | 52,911 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-24 | 2026-09-25 | 8,404 | $190.00 | $1.60M | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-09-24 | 2026-09-25 | 8,404 | $154.96 | $1.30M | 56,773 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-09-21 | 2026-09-22 | 5,426 | — | $0 | 5,426 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-21 | 2026-09-22 | 5,426 | $180.00 | $976.7K | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-09-21 | 2026-09-22 | 5,426 | $141.79 | $769.4K | 53,795 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-09-21 | 2026-09-22 | 5,426 | — | $0 | 5,426 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-21 | 2026-09-22 | 5,426 | $180.00 | $976.7K | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-09-21 | 2026-09-22 | 5,426 | $141.79 | $769.4K | 53,795 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-04 | 2026-09-08 | 3,035 | $165.90 | $503.5K | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-09-04 | 2026-09-08 | 3,035 | $165.90 | $503.5K | 48,369 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-09-03 | 2026-09-08 | 2,842 | $169.61 | $482.0K | 51,404 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-09-03 | 2026-09-08 | 2,842 | $169.61 | $482.0K | 51,404 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-08-20 | 2026-08-21 | 5,426 | — | $0 | 10,852 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-08-20 | 2026-08-21 | 5,426 | $141.79 | $769.4K | 59,672 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-08-20 | 2026-08-21 | 5,426 | $180.00 | $976.7K | 54,246 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise deriv | 2026-08-20 | 2026-08-21 | 5,426 | — | $0 | 10,852 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-08-20 | 2026-08-21 | 5,426 | $180.00 | $976.7K | 54,246 | SEC↗ |
| RGEN REPLIGEN CORP | M Exercise | 2026-08-20 | 2026-08-21 | 5,426 | $141.79 | $769.4K | 59,672 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2026-04-21 | 2026-04-22 | 3,832 | $140.00 | $536.5K | 54,246 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2026-03-05 | 2026-03-23 | 25,890 | — | $0 | 25,890 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2026-03-05 | 2026-03-23 | 24,134 | — | $0 | 58,078 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-03-02 | 2026-03-03 | 1,610 | $124.97 | $201.2K | 33,944 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2026-02-27 | 2026-03-03 | 344 | $128.73 | $44.3K | 35,554 | SEC↗ |
| RGEN REPLIGEN CORP | S Sale | 2025-11-25 | 2025-11-26 | 7,041 | $170.00 | $1.20M | 35,898 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-10-02 | 2025-10-06 | 1,248 | $145.23 | $181.2K | 42,939 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-09-03 | 2025-09-04 | 2,506 | $116.18 | $291.1K | 44,187 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2025-03-03 | 2025-03-04 | 13,627 | — | $0 | 13,627 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2025-03-03 | 2025-03-04 | 14,480 | — | $0 | 46,693 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2025-02-27 | 2025-02-28 | 343 | $156.54 | $53.7K | 32,213 | SEC↗ |
| RGEN REPLIGEN CORP | F Tax w/h | 2024-11-20 | 2024-11-21 | 861 | $123.41 | $106.3K | 32,556 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2024-09-03 | 2024-09-04 | 16,278 | — | $0 | 16,278 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2024-09-03 | 2024-09-04 | 17,631 | — | $0 | 33,417 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2024-02-27 | 2024-02-29 | 2,860 | — | $0 | 2,860 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2024-02-27 | 2024-02-29 | 2,880 | — | $0 | 15,786 | SEC↗ |
| RGEN REPLIGEN CORP | A Award deriv | 2023-10-02 | 2023-10-03 | 24,236 | — | $0 | 24,236 | SEC↗ |
| RGEN REPLIGEN CORP | A Award | 2023-10-02 | 2023-10-03 | 12,906 | — | $0 | 12,906 | SEC↗ |